Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1994 Mar;85(3):231–237. doi: 10.1111/j.1349-7006.1994.tb02087.x

Mortality among Inhabitants of an HTLV‐I Endemic Area in Japan

Kokichi Iwata 1,✉, Shin‐ichiro Ito 2, Hiroshi Saito 1, Mizuko Ito 2, Masazumi Nagatomo 3, Tomihiro Yamasaki 1, Shigeyuki Yoshida 4, Hisatsugu Suto 5, Kazuo Tajima 6
PMCID: PMC5919449  PMID: 8188520

Abstract

A community‐based cohort study was conducted to clarify the risk of human T‐cell leukemia virus type I (HTLV‐I) infection for cause‐specific deaths. A total of 1,997 individuals (751 men and 1,246 women) aged 30 or older in A‐IsIand, Nagasaki Prefecture, Japan who had voluntarily attended annual mass health examinations, including serum HTLV‐I antibody test, were followed up for a mean period of 5.3 years. In a Cox proportional hazards analysis adjusted for age at baseline, the HTLV‐I seropositivity was found to be associated with mortality from all causes in men (hazard ratio (HR) 1.89; 95% confidence interval (CD 1.01–3.54) and women (HR 1.94; 95% CI 1.16–3.22). When the effects of 2 deaths (1 man and 1 woman) from adult T‐cell leukemia/lymphoma (ATL) were excluded, the mortality risk decreased slightly but was still significantly or marginally significantly greater than 1 in both men (HR 1.77; 95% CI 0.93–3.37) and women (HR 1.87; 95% CI 1.12–3.12). Further analysis of cause‐specific deaths revealed a significant increase in the risk for non‐neoplastic diseases but not for neoplasms excluding ATL. These findings suggest that long‐term HTLV‐I infection represents a health hazard greater than just that for the development of ATL. It was difficult, however, to draw a conclusion regarding the association between HTLV‐I infection and cancer risk, because the number of cancer deaths was small and the incidence of cancer was not investigated.

Keywords: HTLV‐I carrier, Mortality, Prospective cohort study

Full Text

The Full Text of this article is available as a PDF (432.4 KB).

REFERENCES

  • 1. ) Poiesz , B. J. , Ruscetti , F. W. , Gazdar , A. F. , Bunn , P. A. , Minna , J. D. and Gallo , R. C.Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T‐cell lymphoma . Proc. Natl. Acad. Sci. USA , 77 , 7415 – 7419 ( 1980. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. ) Hinuma , Y. , Nagata , K. , Hanaoka , M. , Nakai , M. , Matsumoto , T. , Kinoshita , K. , Shirakawa , S. and Miyoshi , I.Adult‐T‐cell leukemia: antigen in an ATL cell line and the detection of antibodies to the antigen in human sera . Proc. Natl. Acad. Sci. USA , 78 , 6476 – 6480 ( 1981. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. ) Hinuma , Y. , Komoda , H. , Chosa , T. , Kondo , T. , Kohakura , M. , Takenaka , T. , Kikuchi , M. , Ichimaru , M. , Yunoki , K. , Sato , I. , Matsuo , R. , Takiuchi , Y. , Uchino , H. and Hanaoka , M.Antibodies to adult T‐cell leukemiavirus‐associated‐antigen (ATLA) in sera from patients with ATL and controls in Japan: a nationwide seroepidemiologic study . Int. J. Cancer , 29 , 631 – 635 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Murphy , E. L. , Hanchard , B. , Figueroa , J. P. , Gibbs , W. N. , Lofters , W. S. , Campbell , M. , Goedert , J. J. and Blattner , W. A.Modeling the risk of adult T‐cell leukemia/lymphoma in persons infected with human T‐lymphotropicvirus type I . Int. J. Cancer , 43 , 250 – 253 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Delaporte , E. , Dupont , A. , Peeters , M. , Josse , R. , Merlin , M. , Schrijvers , D. , Hamono , B. , Bedjabaga , L. , Cheringou , H. , Boyer , F. , Brun‐Vezinet , F. and Larouze , B.Epidemiology of HTLV‐I in Gabon (western equatorial Africa) . Int. J. Cancer , 42 , 687 – 689 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Tajima , K. , The T‐ and B‐cell Malignancy Study Group and Co‐authors. The 4th nation‐wide study of adult T‐cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features . Int. J. Cancer , 45 , 237 – 243 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Gessain , A. , Barin , F. , Vernant , J. C. , Gout , O. , Maurs , L. , Calender , A. and de Thé , G.Antibodies to human T‐lymphotropicvirus type‐I in patients with tropical spastic paraparesis . Lancet , ii , 407 – 410 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Osame , M. , Usuku , K. , Izumo , S. , Ijiri , N. , Amitani , H. , Igata , A. , Matsumoto , M. and Tara , M.HTLV‐I associated myelopathy, a new clinical entity . Lancet , i , 1031 – 1032 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Nishioka , K. , Maruyama , I. , Sato , K. , Kitajima , I. , Nakajima , Y. and Osame , M.Chronic inflammatory arthropathy associated with HTLV‐I . Lancet , i , 441 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Sugimoto , M. , Nakashima , H. , Watanabe , S. , Uyama , E. , Tanaka , F. , Ando , M. , Araki , S. and Kawasaki , S.T‐lymphocyte alveolitis in HTLV‐I‐associated myelopathy . Lancet , i , 1220 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Nakao , K. , Ohba , N. and Matsumoto , M.Noninfectious anterior uveitis in patients infected with human T‐lymphotropicvirus type I . Jpn. J. Ophthalmol. , 33 , 472 – 481 ( 1989. ). [PubMed] [Google Scholar]
  • 12. ) Katsuki , T. , Katsuki , K. , Imai , J. and Hinuma , Y.Immune suppression in healthy carriers of adult T‐cell leukemia retrovirus (HTLV‐I): impairment of T‐cell control of Epstein‐Barr virus‐infected B‐cells . Jpn. J. Cancer Res. , 78 , 639 – 642 ( 1987. ). [PubMed] [Google Scholar]
  • 13. ) Tachibana , N. , Okayama , A. , Ishizaki , J. , Yokota , T. , Shishime , E. , Murai , K. , Shioiri , S. , Tsuda , K. , Essex , M. and Mueller , N.Suppression of tuberculin skin reaction in healthy HTLV‐I carriers from Japan . Int. J. Cancer , 42 , 829 – 831 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Nakada , K. , Kohakura , M. , Komoda , H. and Hinuma , Y.High incidence of HTLV antibody in carriers of strongyloides stercoralis . Lancet , i , 633 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Yamaguchi , K. , Kiyokawa , T. , Nakada , K. , Lee , S. Y. , Asou , N. , Ishii , T. , Sanada , I. , Seiki , M. , Yoshida , M. , Matutes , E. , Catovsky , D. and Takatsuki , K.Polyclonal integration of HTLV‐I proviral DNA in lymphocytes from HTLV‐I seropositive individuals: an intermediate state between the healthy carrier state and smoldering ATL . Br. J. Hematol. , 68 , 169 – 174 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Khono , S. , Koga , H. , Kaku , M. , Yasuoka , A. , Maesaki , S. , Tanaka , K. , Mitsutake , K. , Matsuda , H. , Araki , J. and Hara , K.Prevalence of HTLV‐I antibody in pulmonary cryptococcosis . Tohoku J. Exp. Med. , 167 , 13 – 18 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Asou , N. , Kumagai , T. , Uekihara , S. , Ishii , M. , Sato , M. , Sakai , K. , Nishimura , H. , Yamaguchi , K. and Takatsuki , K.HTLV‐I seroprevalence in patients with malignancy . Cancer , 58 , 903 – 907 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Miyazaki , K. , Yamaguchi , K. , Tohya , T. , Ohba , T. , Takatsuki , K. and Okamura , H.Human‐T‐cell leukemia virus type I infection as an oncogenic and prognostic risk factor in cervical and vaginal carcinoma . Obstet. Gynecol. , 77 , 107 – 110 ( 1991. ). [PubMed] [Google Scholar]
  • 19. ) Lee , S. Y. , Matsushita , K. , Machida , J. , Tajiri , M. , Yamaguchi , K. and Takatsuki , K.Human T‐cell leukemia virus type I infection in hemodialysis patients . Cancer , 60 , 1474 – 1478 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Tokudome , S. , Maeda , Y. , Fukada , K. , Teshima , D. , Asakura , T. , Sueoka , E. , Motomura , Y. , Kusumoto , Y. , Imamura , Y. , Kiyokawa , T. , Ikeda , M. and Tokunaga , O.Follow‐up of asymptomatic HTLV‐I carriers among blood donors in Kyushu, Japan . Cancer Causes Control , 2 , 75 – 78 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Tajima , K. and Kuroishi , T.Estimation of rate of incidence of ATL among ATLV (HTLV‐I) carriers in Kyushu, Japan . Jpn. J. Clin. Oncol. , 15 , 423 – 430 ( 1985. ). [PubMed] [Google Scholar]
  • 22. ) Tajima , K. , Kamura , S. , Ito , S. , Ito , M. , Nagatomo , M. , Kinoshita , K. and Ikeda , S.Epidemiological features of HTLV‐I carriers and incidence of ATL in an ATL‐endemic island: a report of the community‐based cooperative study in Tsushima, Japan . Int. J. Cancer , 40 , 741 – 746 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Tokudome , S. , Tokunaga , O. , Shimamoto , Y. , Miyamoto , Y. , Sumida , I. , Kikuchi , M. , Takeshita , M. , Ikeda , T. , Fujiwara , K. , Yoshihara , M. , Yanagawa , T. and Nishizumi , M.Incidence of adult‐T‐cell leukemia/lymphoma among human T‐lymphotropic virus type I carriers in Saga, Japan . Cancer Res. , 49 , 226 – 228 ( 1989. ). [PubMed] [Google Scholar]
  • 24. ) Kondo , T. , Kono , H. , Miyamoto , N. , Yoshida , R. , Toki , H. , Matsumoto , I. , Hara , M. , Inoue , H. , Inatsuki , A. , Funatsu , T. , Yamano , N. , Bando , F. , Iwao , E. , Miyoshi , I. , Hinuma , Y. and Hanaoka , M.Age‐ and sex‐specific cumulative rate and risk of ATLL for HTLV‐I carriers . Int. J. Cancer , 43 , 1061 – 1064 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Ikeda , M. , Fujino , R. , Matsui , T. , Yoshida , T. , Komoda , H. and Imai , J.A new agglutination test for serum antibodies to adult T‐cell leukemia virus . Gann , 75 , 845 – 848 ( 1984. ). [PubMed] [Google Scholar]
  • 26. ) Maeda , Y. , Imai , J. , Kiyokawa , H. , Kanamura , M. and Hino , S.Performance certification of gelatin particle agglutination assay for anti‐HTLV‐I antibody: inconclusive positive results . Jpn. J. Cancer Res. , 80 , 915 – 919 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. ) Kwon , K. W. , Ikeda , H. , Yano , M. and Sekiguchi , S.Evaluation of the human T‐cell leukemia virus type I seropositivity of blood donors by the particle agglutination inhibition test . Jpn. J. Cancer Res. , 80 , 833 – 839 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. ) Ransohoff , D. F. and Feinstein , A. R.Problems of spectrum and bias in evaluating the efficacy of diagnostic tests . N. Eng. J. Med. , 299 , 926 – 930 ( 1978. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Kinoshita , T. , Imamura , J. , Nagai , H. , Ito , M. , Ito , S. , Ikeda , S. , Nagatomo , M. , Tajima , K. and Shimotohno , K.Absence of HTLV‐I infection among seronegative subjects in an endemic area of Japan . Int. J. Cancer , 54 , 16 – 19 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Harrell , F. E.The PHGLM procedure . In “ Supplementary User's Guide ,” pp. 267 – 294 ( 1983. ). SAS Institute; , Gary , North Carolina . [Google Scholar]
  • 31. ) Stuver , S. O. , Tachibana , N. and Mueller , N.Case‐control study of factors associated with human T‐cell leukemia virus type‐I infection in southern Miyazaki, Japan . J. Natl. Cancer Inst. , 84 , 867 – 872 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Miyoshi , I. , Yoshimoto , S. , Ohtsuki , Y. , Fujishita , M. , Akagi , T. , Yoshiki , T. and Koike , T.Adult T‐cell leukemia antigen in renal glomerulus . Lancet , i , 768 – 769 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Kaplan , J. E. , Osame , M. , Kubota , H. , Igata , A. , Nishitani , H. , Maeda , Y. , Khabbaz , R. F. and Janssen , R. S.The risk of development of HTLV‐I‐associated myelopathy/tropical spastic paraparesis among persons infected with HTLV‐I . J. Acquired Immune Defic. Syndr. , 3 , 1096 – 1101 ( 1990. ). [PubMed] [Google Scholar]
  • 34. ) Willet , W. C.Correction for the effects of measurement error . In “ Nutritional Epidemiology ,” pp. 272 – 291 ( 1990. ). Oxford University Press; , New York . [Google Scholar]
  • 35. ) Fujino , R. , Kawato , K. , Ikeda , M. , Miyakoshi , H. , Mizukoshi , M. and Imai , J.Improvement of gelatin particle agglutination test for detection of anti‐HTLV‐I antibody . Jpn. J. Cancer Res. , 82 , 367 – 370 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES